- Home
- UUUU vs VKTX Comparison
UUUU vs VKTX Comparison
Compare UUUU & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UUUU | VKTX |
|---|---|---|
| Founded | 1987 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 2006 | 2014 |
Fundamental Metrics
Financial Performance| Metric | UUUU | VKTX |
|---|---|---|
| Price | $19.91 | $35.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $19.92 | ★ $88.00 |
| AVG Volume (30 Days) | ★ 9.0M | 2.6M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $65,922,000.00 | N/A |
| Revenue This Year | $113.24 | N/A |
| Revenue Next Year | $36.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.20 | $18.92 |
| 52 Week High | $27.90 | $43.15 |
Technical Indicators
Market Signals| Indicator | UUUU | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 58.57 |
| Support Level | $19.34 | $33.65 |
| Resistance Level | $23.61 | $35.66 |
| Average True Range (ATR) | 1.70 | 1.73 |
| MACD | -0.28 | 0.38 |
| Stochastic Oscillator | 24.34 | 77.28 |
Price Performance
Historical ComparisonAbout UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.